These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18348300)

  • 1. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
    von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
    Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressiveness of cancer-care near the end-of-life in Korea.
    Keam B; Oh DY; Lee SH; Kim DW; Kim MR; Im SA; Kim TY; Bang YJ; Heo DS
    Jpn J Clin Oncol; 2008 May; 38(5):381-6. PubMed ID: 18411260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment.
    Aletti GD; Podratz KC; Cliby WA; Gostout BS
    Gynecol Oncol; 2009 Jan; 112(1):22-7. PubMed ID: 18947860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
    Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
    J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer.
    Uyar D; Frasure HE; Markman M; von Gruenigen VE
    Gynecol Oncol; 2005 Sep; 98(3):403-8. PubMed ID: 16000216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis.
    Braga S; Miranda A; Fonseca R; Passos-Coelho JL; Fernandes A; Costa JD; Moreira A
    Psychooncology; 2007 Sep; 16(9):863-8. PubMed ID: 17245696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer.
    Sharma S; Rezai K; Driscoll D; Odunsi K; Lele S
    Gynecol Oncol; 2006 Oct; 103(1):181-5. PubMed ID: 16574203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN; Buttin BM; Powell MA; Gibb RK; Rader JS; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
    Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of hospital type on the efficacy of chemotherapy treatment in ovarian cancer patients.
    Vernooij F; Witteveen PO; Verweij E; van der Graaf Y; Heintz AP
    Gynecol Oncol; 2009 Dec; 115(3):343-8. PubMed ID: 19800674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
    Su D; Smith SM; Preti M; Schwartz P; Rutherford TJ; Menato G; Danese S; Ma S; Yu H; Katsaros D
    Cancer; 2009 Jun; 115(11):2453-63. PubMed ID: 19322891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
    Karam AK; Chiang JW; Fung E; Nossov V; Karlan BY
    Gynecol Oncol; 2009 Aug; 114(2):246-52. PubMed ID: 19500821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of symptoms in terminally ill patients with ovarian carcinoma].
    Sun XG; Wu M; Ma SQ; Li CY; Jin LN; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):192-5. PubMed ID: 17537307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.